Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAOB | P27338 | 7/20 | 0.38 |
| ▸ | MAOA | P21397 | 4/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | SIRT2 | Q8IXJ6 | 5/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | IL5 | P05113 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17175233 | 0.82 | KDM4E (0.31) | ALDH1A1KDM4E | |
| SCHEMBL15713304 | 0.77 | ALDH1A1 (0.38) | ALDH1A1MAOBMAOACYP1A2SIRT2 | |
| SCHEMBL7432912 | 0.65 | CYP1A2 (0.57) | ALDH1A1CYP1A2SIRT2KDM4ELMNA | |
| SCHEMBL19340013 | 0.65 | MAOA (0.56) | ALDH1A1MAOBMAOACYP1A2KDM4E | |
| SCHEMBL607927 | 0.64 | CYP1A2 (0.71) | ALDH1A1CYP1A2KDM4ELMNAGAA | |
| SCHEMBL17776049 | 0.63 | GNG2 (0.53) | ALDH1A1CYP1A2LMNAGAAHPGD | |
| SCHEMBL597341 | 0.62 | CYP1A2 (0.67) | ALDH1A1CYP1A2KDM4ELMNAGAA | |
| SCHEMBL17175235 | 0.62 | CYP19A1 (0.31) | — | |
| SCHEMBL17175231 | 0.62 | TYMS (0.31) | MAOBMAOA | |
| SCHEMBL9644313 | 0.62 | CYP2A6 (0.56) | ALDH1A1MAOBMAOACYP1A2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150295179-A1 | MONOMERIC, OLIGOMERIC AND POLYMERIC SEMICONDUCTORS CONTAINING FUSED RINGS AND THEIR DEVICES | LI YUNING (US) | 2015-10-15 | — | — | US | disclosed |
| US-20150295179-A1 | MONOMERIC, OLIGOMERIC AND POLYMERIC SEMICONDUCTORS CONTAINING FUSED RINGS AND THEIR DEVICES | LI YUNING (US) | 2015-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150295179-A1 | MONOMERIC, OLIGOMERIC AND POLYMERIC SEMICONDUCTORS CONTAINING FUSED RINGS AND THEIR DEVICES | PICALM, NOD2, CDH1 | ALDH1A1 4649/4885MAOB 3053/4885MAOA 2391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.